Back
C4 Therapeutics, Inc. Stock Price Chart
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
34
CCCC
C4 Therapeutics, Inc.
Last Price:
$2.68
Seasonality Move:
-24.32%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CCCC is experiencing slight buying pressure.
C4 Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.61 | Buy |
| 20-day SMA: | 2.51 | Buy |
| 50-day SMA: | 2.41 | Buy |
| 200-day SMA: | 2.1 | Buy |
| 8-day EMA: | 2.61 | Buy |
| 20-day EMA: | 2.54 | Buy |
| 50-day EMA: | 2.43 | Buy |
| 200-day EMA: | 1.5 | Buy |
C4 Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 55.22 | Buy |
| Chaikin Money Flow: | 107201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.36 - 2.62) | Buy |
| Bollinger Bands (100): | (2.19 - 2.75) | Buy |
C4 Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for C4 Therapeutics, Inc. Stock
Is C4 Therapeutics, Inc. Stock a Buy?
-
C4 Therapeutics, Inc. share price is 2.67 while CCCC 8-day simple moving average is 2.61, which is a Buy signal.
-
The stock price of CCCC is 2.67 while C4 Therapeutics, Inc. 20-day SMA is 2.51, which makes it a Buy.
-
C4 Therapeutics, Inc. 50-day simple moving average is 2.41 while CCCC share price is 2.67, making it a Buy technically.
-
CCCC stock price is 2.67 and C4 Therapeutics, Inc. 200-day simple moving average is 2.10, creating a Buy signal.
CCCC Technical Analysis vs Fundamental Analysis
Sell
34
C4 Therapeutics, Inc. (CCCC)
is a Sell
Is C4 Therapeutics, Inc. a Buy or a Sell?
-
C4 Therapeutics, Inc. stock is rated a SellThe current C4 Therapeutics, Inc. [CCCC] share price is $2.67. The Score for CCCC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
C4 Therapeutics, Inc. Stock Info
Market Cap:
258.8M
Price in USD:
2.67
Share Volume:
2M
C4 Therapeutics, Inc. 52-Week Range
52-Week High:
5.10
52-Week Low:
1.09
Sell
34
C4 Therapeutics, Inc. (CCCC)
is a Sell
C4 Therapeutics, Inc. Share Price Forecast
-
What is the C4 Therapeutics, Inc. stock price today?The C4 Therapeutics, Inc. stock price is 2.67 USD today.
-
Will CCCC stock go up or go down?C4 Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is C4 Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, C4 Therapeutics, Inc. is overvalued.
Is C4 Therapeutics, Inc. Stock a Buy?
-
C4 Therapeutics, Inc. share price is 2.67 while CCCC 8-day exponential moving average is 2.61, which is a Buy signal.
-
The stock price of CCCC is 2.67 while C4 Therapeutics, Inc. 20-day EMA is 2.54, which makes it a Buy.
-
C4 Therapeutics, Inc. 50-day exponential moving average is 2.43 while CCCC share price is 2.67, making it a Buy technically.
-
CCCC stock price is 2.67 and C4 Therapeutics, Inc. 200-day simple moving average is 1.50, creating a Buy signal.
Fundamental Analysis of C4 Therapeutics, Inc.
Is C4 Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and an increase next year of $0.23 per share.
Technical Analysis of C4 Therapeutics, Inc.
Should I short C4 Therapeutics, Inc. stock?
-
CCCC Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting C4 Therapeutics, Inc. is a Buy
-
C4 Therapeutics, Inc. Relative Strength Index (RSI) is 55.22, which suggest C4 Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for C4 Therapeutics, Inc. is (2.36 - 2.62), which suggest C4 Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for C4 Therapeutics, Inc. is (2.19 - 2.75), which suggest C4 Therapeutics, Inc. is a Buy
* C4 Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.